Transgene SA (EPA:TNG)
France · Delayed Price · Currency is EUR 0.7800
0.00 (0.00%)
At close: Mar 13, 2026
Transgene Market Cap
Transgene has a market cap or net worth of €213.59 million as of March 13, 2026. Its market cap has increased by 129.86% in one year.
Market Cap
213.59M
Enterprise Value
227.88M
Revenue
7.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.78
Market Cap Chart
Since March 30, 1998, Transgene's market cap has increased from 151.86M to 213.59M, an increase of 40.65%. That is a compound annual growth rate of 1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 213.59M | -18.75% |
| Dec 31, 2025 | 262.87M | 192.89% |
| Dec 31, 2024 | 89.75M | -34.86% |
| Dec 29, 2023 | 137.78M | -16.38% |
| Dec 30, 2022 | 164.76M | -33.52% |
| Dec 31, 2021 | 247.84M | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 831.23M |
| MedinCell | 746.81M |
| Genfit | 433.47M |
| Cellectis | 243.74M |
| Sensorion | 165.19M |
| MaaT Pharma | 134.35M |
| Innate Pharma | 126.53M |
| Adocia | 118.93M |